Inmed Pharmaceuticals INC. (INM) — 10-Q Filings

10-Q Filings (6)

• InMed Pharma's Q1 Loss Widens, Revenue Dips Amid Going Concern Doubts — Nov 6, 2025 Risk: high
  InMed Pharmaceuticals Inc. reported a net loss of $1,726,899 for the three months ended September 30, 2025, a slight increase from the $1,677,868 net loss in th
• InMed Pharmaceuticals Files Q1 2025 10-Q — May 12, 2025 Risk: low
  InMed Pharmaceuticals Inc. filed its quarterly report for the period ending March 31, 2025. The company, incorporated in British Columbia, Canada, operates in t
• InMed Pharmaceuticals Files Q3 2024 10-Q — Feb 12, 2025 Risk: medium
  InMed Pharmaceuticals Inc. filed its 10-Q for the quarterly period ended December 31, 2024. The company, incorporated in British Columbia, Canada, is involved i
• InMed Pharmaceuticals Files Q3 2024 Report — Nov 14, 2024 Risk: medium
  InMed Pharmaceuticals Inc. filed its quarterly report for the period ending September 30, 2024. The company, based in Vancouver, Canada, is involved in the phar
• InMed Pharmaceuticals Inc. Files 10-Q for Period Ended March 31, 2024 — May 14, 2024 Risk: low
  InMed Pharmaceuticals Inc. (INM) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. InMed Pharmaceuticals Inc. filed a 10-Q quarterly report for the
• InMed Pharmaceuticals Inc. Files 10-Q for Period Ended December 31, 2023 — Feb 13, 2024 Risk: low
  InMed Pharmaceuticals Inc. (INM) filed a Quarterly Report (10-Q) with the SEC on February 13, 2024. InMed Pharmaceuticals Inc. filed a 10-Q report for the quart

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX